Cybin (HELP) Cash from Operations (2020 - 2026)
Cybin (HELP) posted quarterly Cash from Operations of 37291000.0 for Q1 2026, down 153.44% year-on-year from 69782442.13 in Q1 2025, and down 16.73% on a QoQ basis from 31947000.0 in Q4 2025.
Cybin (HELP) Cash from Operations (2020 - 2026) Analysis & Trends
Cybin (HELP) has reported Cash from Operations for 7 consecutive years, with 37291000.0 the latest figure, recorded in Q1 2026.
- Quarterly Cash from Operations fell 153.44% year-over-year to 37291000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 133271000.0 (down 84.31% YoY) and the FY2026 annual result came in at 133271000.0, down 84.26% from the prior year.
- Cash from Operations eased to 37291000.0 in Q1 2026 per HELP's latest filing, from 31947000.0 in the prior quarter.
- Over the last five years, Cash from Operations for HELP reached as high as 4960037.03 in Q2 2022 and fell as low as 37291000.0 in Q1 2026.
- A 5-year average of 18054856.29 and a median of 18593000.0 in 2024 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2023 — Cash from Operations advanced 24.05% — and 2026, when it tumbled 153.44%.
- Year by year, Cash from Operations stood at 7935027.37 in 2022, then sank by 141.07% to 19128774.2 in 2023, then rose by 2.8% to 18593000.0 in 2024, then sank by 71.82% to 31947000.0 in 2025, then decreased by 16.73% to 37291000.0 in 2026.
- According to Business Quant data, Cash from Operations over the past three periods registered 37291000.0, 31947000.0, and 34485000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Cybin | 28.04 Mn | 28.04 Mn | - | -37.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -37.29 Mn |
| Mar 31, 2026 | -37.29 Mn |
| Dec 31, 2025 | -31.95 Mn |
| Dec 31, 2025 | -31.95 Mn |
| Sep 30, 2025 | -34.49 Mn |
| Sep 30, 2025 | -34.49 Mn |
| Jun 30, 2025 | -29.55 Mn |
| Jun 30, 2025 | -29.55 Mn |
| Mar 31, 2025 | -14.71 Mn |
| Mar 31, 2025 | -14.71 Mn |
| Dec 31, 2024 | -18.59 Mn |
| Dec 31, 2024 | -18.59 Mn |
| Sep 30, 2024 | -19.11 Mn |
| Sep 30, 2024 | -19.11 Mn |
| Jun 30, 2024 | -19.89 Mn |
| Jun 30, 2024 | -19.89 Mn |
| Mar 31, 2024 | -15.37 Mn |
| Mar 31, 2024 | -15.37 Mn |
| Dec 31, 2023 | -19.13 Mn |
| Dec 31, 2023 | -19.13 Mn |